Alzheimer’s drug donanemab: what promising trial means for treatments
Sara Reardon
Topics & Concepts
DrugCognitive declineDrug trialCognitionDrug candidateAmyloid (mycology)Drug discoveryMedicinePharmacologyNeurosciencePsychologyDementiaBioinformaticsPsychiatryClinical trialBiologyInternal medicineDiseasePathologyAlzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases